CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 12 enrolled
Drug / intervention
3D OCT-1 Maestrodevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02447133
NCT02447133N/ACompleted
CompareCT.gov

TopQ Cut-off Score Validation Study for 3D OCT-1 Maestro

Topcon Medical Systems, Inc.·observational·Posted May 18, 2015·Updated Jun 29, 2022

In Brief

An observational study evaluating 3D OCT-1 Maestro for Subjects Presenting With Normal Eyes. Completed, enrolled 12 participants across 1 site.

Detailed Summary

The objective of this study is to validate the TopQ cutoff scores, which have been previously determined.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSubjects Presenting With Normal Eyes
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedMay 18, 2015
Enrollment StartMay 1, 2015
Primary CompletionMay 1, 2015
TodayJul 2, 2026
Enrollment to primary: 0 daysPosted 11.1 years ago

Interventions

3D OCT-1 Maestrodevice

OCT Machine used for diagnostic purposes